These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9697721)

  • 1. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus.
    Perno CF; Newcomb FM; Davis DA; Aquaro S; Humphrey RW; Caliò R; Yarchoan R
    J Infect Dis; 1998 Aug; 178(2):413-22. PubMed ID: 9697721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro.
    Panther LA; Coombs RW; Aung SA; dela Rosa C; Gretch D; Corey L
    J Med Virol; 1999 Jun; 58(2):165-73. PubMed ID: 10335865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages.
    Perno CF; Bergamini A; Pesce CD; Milanese G; Capozzi M; Aquaro S; Thaisrivongs S; Tarpley WG; Zon G; D'Agostini C
    J Infect Dis; 1993 Nov; 168(5):1148-56. PubMed ID: 8228348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
    Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
    Mengoni F; Lichtner M; Battinelli L; Marzi M; Mastroianni CM; Vullo V; Mazzanti G
    Planta Med; 2002 Feb; 68(2):111-4. PubMed ID: 11859458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Amprenavir on HIV-1 Maturation, Production and Infectivity Following Drug Withdrawal in Chronically-Infected Monocytes/Macrophages.
    Borrajo A; Ranazzi A; Pollicita M; Bruno R; Modesti A; Alteri C; Perno CF; Svicher V; Aquaro S
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28956865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.
    Bender AR; von Briesen H; Kreuter J; Duncan IB; Rübsamen-Waigmann H
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1467-71. PubMed ID: 8726020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophages.
    Davis DA; Read-Connole E; Pearson K; Fales HM; Newcomb FM; Moskovitz J; Yarchoan R
    Antimicrob Agents Chemother; 2002 Feb; 46(2):402-8. PubMed ID: 11796349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.
    Chiang G; Sassaroli M; Louie M; Chen H; Stecher VJ; Sperber K
    Clin Ther; 1996; 18(6):1080-92. PubMed ID: 9001825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effect of alpha1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: a comparative study with other relevant HIV protease inhibitors.
    Lazdins JK; Mestan J; Goutte G; Walker MR; Bold G; Capraro HG; Klimkait T
    J Infect Dis; 1997 May; 175(5):1063-70. PubMed ID: 9129067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
    Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
    Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug susceptibility of subtypes A,B,C,D, and E human immunodeficiency virus type 1 primary isolates.
    Palmer S; Alaeus A; Albert J; Cox S
    AIDS Res Hum Retroviruses; 1998 Jan; 14(2):157-62. PubMed ID: 9462926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus type 1 replication by combination of transcription inhibitor K-12 and other antiretroviral agents in acutely and chronically infected cells.
    Okamoto M; Okamoto T; Baba M
    Antimicrob Agents Chemother; 1999 Mar; 43(3):492-7. PubMed ID: 10049256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes.
    Aquaro S; Perno CF; Balestra E; Balzarini J; Cenci A; Francesconi M; Panti S; Serra F; Villani N; Caliò R
    J Leukoc Biol; 1997 Jul; 62(1):138-43. PubMed ID: 9226005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HIV: to administer protease inhibitors early].
    Dtsch Med Wochenschr; 1996 Dec; 121(49):A49. PubMed ID: 8998916
    [No Abstract]   [Full Text] [Related]  

  • 16. A new contained human immunodeficiency virus type 1 host cell system for evaluation of antiviral activities of interferons and other agents in vitro.
    Moussazadeh M; Hua J; Sidhu MK; Zhao XX; Fitzgibbon JE; Liao MJ; Rashidbaigi A
    Antiviral Res; 1999 Jul; 42(3):177-87. PubMed ID: 10443530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the effect of temporary removal of HIV drug pressure.
    Witvrouw M; Pannecouque C; Desmyter J; De Clercq E; Andries K
    Antiviral Res; 2000 Jun; 46(3):215-21. PubMed ID: 10867159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV replication and macrophage colony-stimulating factor production in human macrophages by antiretroviral agents.
    Kutza J; Fields K; Grimm TA; Clouse KA
    AIDS Res Hum Retroviruses; 2002 Jun; 18(9):619-25. PubMed ID: 12079557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity of UIC-PI, a novel inhibitor of the human immunodeficiency virus type 1 protease.
    Ghosh AK; Pretzer E; Cho H; Hussain KA; Düzgüneş N
    Antiviral Res; 2002 Apr; 54(1):29-36. PubMed ID: 11888655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 protease does not play a critical role in the early stages of HIV-1 infection.
    Uchida H; Maeda Y; Mitsuya H
    Antiviral Res; 1997 Nov; 36(2):107-13. PubMed ID: 9443667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.